Amgen News - AMGN

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.98 -0.45% 218.21 215.70 219.35 217.40 219.19 00:00:02
more quote information »

Recent News

Date Time Source Heading
4/07/202020:35PRNUSAmgen And Adaptive Biotechnologies To Participate In Webinar..
4/07/202016:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/07/202016:03EDGARProxy Statement (definitive) (def 14a)
4/02/202009:00PRNUSAmgen And Adaptive Biotechnologies Announce Strategic..
3/31/202020:00PRNUSAmgen Establishes Wholly-Owned Affiliate In Japan
3/31/202008:35EDGARCurrent Report Filing (8-k)
3/28/202010:00PRNUSAmgen Announces Positive Results At ACC.20/WCC From Phase 3B..
3/24/202018:11EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202018:10EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202018:05EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202018:04EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202018:03EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202018:01EDGARStatement of Changes in Beneficial Ownership (4)
3/24/202017:59EDGARStatement of Changes in Beneficial Ownership (4)
3/23/202016:01PRNUSAmgen And The Amgen Foundation Commit Up To $12.5 Million To..
3/16/202014:29DJNPharmaceutical Firms Curtailing In-Person Sales Calls to..
3/04/202016:04PRNUSAmgen Announces 2020 Second Quarter Dividend
2/27/202020:00PRNUSAmgen To Present At The Cowen 40th Annual Healthcare..
2/26/202015:40DJNAmgen Shares Up, Will Continue Phase 3 Heart Failure Trial
2/26/202010:04DJNAmgen, Cytokinetics to Continue Phase 3 Heart Failure Trial
2/26/202008:30GLOBEAmgen, Cytokinetics and Servier Announce Continuation of..
2/26/202008:30PRNUSAmgen, Cytokinetics And Servier Announce Continuation Of..
2/21/202016:21EDGARCurrent Report Filing (8-k)
2/20/202006:01EDGARProspectus Filed Pursuant to Rule 424(b)(2) (424b2)
2/18/202017:29EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
2/18/202008:46EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
2/14/202012:08EDGARAmended Statement of Ownership (sc 13g/a)
2/13/202013:51EDGARAmended Annual Report (10-k/a)
2/12/202009:28EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202016:50EDGARAutomatic Shelf Registration Statement of Securities of..
2/06/202007:00PRNCALes Canadiens qui survivent à une crise cardiaque prennent..
1/31/202015:44DJNAmgen Down Over 5%, Worst Performer in the Nasdaq 100 So Far..
1/30/202016:46DJNAmgen Forecasts at Least $10.85/Share in 2020 Profit
1/30/202016:42DJNAmgen 4Q Sales Fall, But Still Exceed Wall Street Forecasts
1/30/202016:01PRNUSAmgen Reports Fourth Quarter And Full Year 2019 Financial..
1/27/202016:00PRNUSAmgen Announces Webcast Of 2019 Fourth Quarter And Full Year..
1/22/202009:00PRNUSFree "LabXchange" Science Education Accelerator Launched By..
1/13/202016:20PRNUSAmgen Announces Global Diagnostic Collaborations To Expand..
1/09/202016:00PRNUSAmgen To Present At The 38th Annual J.P. Morgan Healthcare..
1/07/202016:00PRNUSAmgen To Present At The Goldman Sachs 12th Annual Healthcare..
1/02/202008:15GLOBEBeiGene Announces Closing of Amgen Global Strategic Oncology..
1/02/202008:15PRNUSAmgen Commences Strategic Collaboration With BeiGene to..
12/30/201903:02DJNAmgen Steps Up New-Drug Search -- WSJ
12/29/201912:29DJNAmgen Tasks Its Labs With Finding New Blockbusters
12/23/201905:59DJNDrugmakers Turn to Data Mining to Avoid Expensive, Lengthy..
12/19/201916:44PRNUSAmgen And Allergan Submit Biologics License Application For..
12/12/201906:49DJNAmgen, UCB Get EU Approval for Evenity in Osteoporosis
12/12/201901:00PRNUSEuropean Commission Approves EVENITY® (romosozumab) For The..
12/11/201916:00PRNUSAmgen Announces 10% Increase In 2020 First Quarter Dividend
12/10/201908:20DJNAmgen: Phase 3 Study Combining Kyprolis, Darzalex Met..
See more news about this stock »
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200410 06:32:52